Table 1. Baseline demographics and characteristics of patients in control and RD group.
| Characteristics | Control Vit. | SRF of RD | Vit. of RD | P-value |
|---|---|---|---|---|
| Number | 7 | 8 | 8 | |
| Age, years | 70.0 (55–76) | 37.5 (32–52) | 59.0 (45–82) | 0.0005a |
| Sex | ||||
| Female | 3 (42.9) | 4 (50) | 1 (12.5) | NSb |
| Past history | ||||
| Hyperlipidemia | 1 (14.3) | 1 (12.5) | 0 (0) | NSb |
| Diabetic mellitus | 0 (0) | 0 (0) | 1 (12.5) | NSb |
| Hypertension | 0 (0) | 0 (0) | 0 (0) | NSb |
| Surgical indication | ||||
| RRD | — | 8 (100) | 8 (100) | |
| MH | 5 (71.4) | — | ||
| VMTS | 2 (28.6) | — | ||
| Detachment duration, days | — | 3 (1–4) | 8 (0–19) | NSc |
Abbreviations: MH, macular hole; RD, retinal detachment; RRD, rhegmatogenous RD; SRF, subretinal fluid; Vit., vitreous; VMTS, vitreomacular traction syndrome
Data are expressed as median (range) or number (%)
a
Kruskal–Wallis test
b
Fisher's exact test
c
Mann–Whitney U test